Riluzole in the Treatment of Mood and Anxiety Disorders

Author： Pittenger Christopher Coric Vladimir Banasr Mounira

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.9, 2008-01, pp. : 761-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 451-458

Bentham Science Publishers

Access to resources Recommend Favorite

Mood and Anxiety Disorders in Patients with Myasthenia Gravis: Aetiology, Diagnosis and Treatment

By Isin Baral Kulaksizoglu

CNS Drugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 473-481

Adis International

Access to resources Recommend Favorite

Deep Brain Stimulation: A New Treatment in Mood and Anxiety Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 961-971

Bentham Science Publishers

Access to resources Recommend Favorite

Anxiety and Mood Disorders and Cannabis Use

By Cheung Joyce T. W. Mann Robert E. Ialomiteanu Anca Stoduto Gina Chan Vincy Ala-Leppilampi Kari Rehm Jürgen

The American Journal of Drug and Alcohol Abuse, Vol. 36, Iss. 2, 2010-03 ,pp. : 118-122

Informa Healthcare

Access to resources Recommend Favorite

Central functions of neuropeptide Y in mood and anxiety disorders

By Wu Gang Feder Adriana Wegener Gregers Bailey Christopher Saxena Shireen Charney Dennis Mathé Aleksander A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1317-1331

Informa Healthcare

Access to resources Recommend Favorite